NASDAQ:LAVA

LAVA Therapeutics (LAVA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LAVA stock logo

About LAVA Therapeutics Stock (NASDAQ:LAVA)

Magma Design Automation, Inc. (Magma) provides electronic design automation (EDA) software products and related services. Its software enables chip designers to reduce the time it takes to design and produce integrated circuits used in the communications, computing, consumer electronics, networking and semiconductor industries. Its flagship products consist of a digital integrated solution for the chip development cycle, from initial design through physical implementation. Magma’s flagship Talus family of products, its Tekton static timing analyzer and QCP extractor and, its Quartz family of sign-off and verification tools combine into one integrated chip design and verification flow, from what has been separate logic design, physical design, and analysis and sign-off processes. Its Titan platform for custom integrated chip design provides an integrated chip-finishing solution for mixed-signal designs. In February 2012, Synopsys, Inc. acquired the Company.

LAVA Stock News Headlines

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
LVTX Apr 2024 2.500 call
PRGS, EVER and LVTX are among after hour movers
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
What 5 Analyst Ratings Have To Say About LAVA Therapeutics
LAVA Therapeutics (LVTX) Gets a Buy from JMP Securities
See More Headlines
Receive LAVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LAVA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:LAVA) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners